Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro

The activation of innate immunity via myeloid differentiation factor 88 (MyD88) contributes to ischemia reperfusion (I/R) induced acute kidney injury (AKI) and chronic kidney injury. However, since there have not yet been any effective therapy, the exact pharmacological role of MyD88 in the preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li-Min, Liu, Jian-Hua, Xue, Cheng-Biao, Li, Ming-Qiang, Xing, Shuai, Zhang, Xue, He, Wen-Tao, Jiang, Feng-Chao, Lu, Xia, Zhou, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887891/
https://www.ncbi.nlm.nih.gov/pubmed/27246399
http://dx.doi.org/10.1038/srep26954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887891/
https://www.ncbi.nlm.nih.gov/pubmed/27246399
http://dx.doi.org/10.1038/srep26954

Ejemplares similares